These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 1832419)

  • 1. Treatment of severe sepsis in bone marrow transplant recipients with teicoplanin in combination with beta-lactams and aminoglycosides.
    Fauser AA; Lang E; Dölken G; Bross KJ; Schmid J; Sörgel F
    Infection; 1991; 19(3):195-200. PubMed ID: 1832419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A clinical trial on efficacy and safety of teicoplanin in combination with beta-lactams and aminoglycosides in the treatment of severe sepsis of patients undergoing allogeneic/autologous bone marrow transplantation.
    Lang E; Schmid J; Fauser AA
    Br J Haematol; 1990 Dec; 76 Suppl 2():14-8. PubMed ID: 2149045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using teicoplanin for empiric therapy of febrile neutropenic patients with haematological malignancies.
    Menichetti F; Del Favero A; Bucaneve G; Aversa F; Fiorio M
    Br J Haematol; 1990 Dec; 76 Suppl 2():45-8. PubMed ID: 2149052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Teicoplanin in empirical combined antibiotic therapy of bacteraemias in bone marrow transplant patients.
    Menichetti F; Del Favero A; Bucaneve G; Aversa F; Baldelli F; Felicini R; Terenzi A; Pauluzzi S
    J Antimicrob Chemother; 1988 Jan; 21 Suppl A():105-11. PubMed ID: 2965121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective randomized clinical trial of teicoplanin for empiric combined antibiotic therapy in febrile, granulocytopenic acute leukemia patients.
    Del Favero A; Menichetti F; Guerciolini R; Bucaneve G; Baldelli F; Aversa F; Terenzi A; Davis S; Pauluzzi S
    Antimicrob Agents Chemother; 1987 Jul; 31(7):1126-9. PubMed ID: 2959198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized clinical trial of ceftriaxone and teicoplanin versus ceftazidime and teicoplanin as antibiotic therapy in febrile neutropenic cancer patients and bone marrow transplant recipients.
    Fauser AA; Lang E; Köchling G; Daschner FD
    Infection; 1994; 22(4):271-5. PubMed ID: 8002087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Teicoplanin for therapy of gram-positive infections in neutropenic patients.
    Verhagen C; De Pauw BE
    Int J Clin Pharmacol Res; 1987; 7(6):491-8. PubMed ID: 2964418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized prospective study of ceftazidime and ciprofloxacin with or without teicoplanin as an empiric antibiotic regimen for febrile neutropenic patients.
    Lim SH; Smith MP; Goldstone AH; Machin SJ
    Br J Haematol; 1990 Dec; 76 Suppl 2():41-4. PubMed ID: 2149051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Options and limitations of teicoplanin in febrile granulocytopenic patients.
    De Pauw BE; Novakova IR; Donnelly JP
    Br J Haematol; 1990 Dec; 76 Suppl 2():1-5. PubMed ID: 2149042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An open, randomized, multicentre study comparing the use of low-dose ceftazidime or cefotaxime, both in combination with netilmicin, in febrile neutropenic patients. German Multicentre Study Group.
    Höffken G; Pasold R; Pflüger KH; Finke J; Fauser AA; Szelenyi H; Wagner J
    J Antimicrob Chemother; 1999 Sep; 44(3):367-76. PubMed ID: 10511404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized trial comparing netilmicin plus imipenem-cilastatin versus netilmicin plus ceftazidime as empiric therapy for febrile neutropenic bone marrow transplant recipients.
    Laszlo D; Bacci S; Bosi A; Fanci R; Guidi S; Saccardi R; Vannucchi AM; Rossi Ferrini P
    J Chemother; 1997 Apr; 9(2):95-101. PubMed ID: 9176746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Teicoplanin in the treatment of gram-positive bacteraemia in neutropenic patients.
    Micozzi A; Venditti M; Amadori S; Pulsoni A; Tirindelli C; Martino P
    Br J Haematol; 1990 Dec; 76 Suppl 2():19-23. PubMed ID: 2149046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ceftazidime plus amikacin plus teicoplanin or vancomycin in the empirical antibiotic therapy in febrile neutropenic cancer patients.
    Nucci M; Biasoli I; Braggio S; Portugal R; Schaffel R; Maiolino A; Loureiro MM; Spector N; Pulcheri W
    Oncol Rep; 1998; 5(5):1205-9. PubMed ID: 9683836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ceftazidime as monotherapy or combined with teicoplanin for initial empiric treatment of presumed bacteremia in febrile granulocytopenic patients.
    Nováková I; Donnelly JP; De Pauw B
    Antimicrob Agents Chemother; 1991 Apr; 35(4):672-8. PubMed ID: 1829879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective study comparing vancomycin and teicoplanin as second-line empiric therapy for infection in neutropenic patients.
    Cony-Makhoul P; Brossard G; Marit G; Pellegrin JL; Texier-Maugein J; Reiffers J
    Br J Haematol; 1990 Dec; 76 Suppl 2():35-40. PubMed ID: 2149050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy of the combination of teicoplanin or flucloxacillin with netilmicin in the treatment of Staphylococcus aureus bacteraemia.
    Degener JE; Vogel M; Michel MF; Mutsaers MM; Hop WC
    J Antimicrob Chemother; 1989 Jun; 23(6):899-904. PubMed ID: 2527224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multicentre open clinical trial of teicoplanin in infections caused by gram-positive bacteria.
    Lewis P; Garaud JJ; Parenti F
    J Antimicrob Chemother; 1988 Jan; 21 Suppl A():61-7. PubMed ID: 2965133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ceftazidime plus teicoplanin versus ceftazidime plus amikacin as empiric therapy for fever in cancer patients with granulocytopenia.
    Meunier F; Van der Auwera P; Aoun M; Bron D
    Br J Haematol; 1990 Dec; 76 Suppl 2():49-53. PubMed ID: 2149053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Use of ceftazidime combined with netilmicin in the treatment of febrile episodes occurring after bone marrow transplantation in children].
    Couturier C; Storme B; Demeocq F; Sirot J; Malpuech G; Allouche G
    Pathol Biol (Paris); 1988 May; 36(5):562-6. PubMed ID: 3043358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of gram-positive therapy in the neutropenic patient.
    Menichetti F; Del Favero A
    J Antimicrob Chemother; 1991 Apr; 27 Suppl B():51-60. PubMed ID: 1829077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.